These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 4991431)

  • 1. The effect of coumermycin A on the meningococcal carrier state.
    Devine LF; Johnson DP; Hagerman CR; Pierce WE; Rhode SL; Peckinpaugh RO
    Am J Med Sci; 1970 Sep; 260(3):165-70. PubMed ID: 4991431
    [No Abstract]   [Full Text] [Related]  

  • 2. In-vitro and in-vivo studies of resistance to rifampin in meningococci.
    Eickhoff TC
    J Infect Dis; 1971 Apr; 123(4):414-20. PubMed ID: 4999905
    [No Abstract]   [Full Text] [Related]  

  • 3. Rifampin. Levels in serum and saliva and effect on the meningococcal carrier state.
    Devine LF; Johnson DP; Hagerman CR; Pierce WE; Rhode SL; Peckinpaugh RO
    JAMA; 1970 Nov; 214(6):1055-9. PubMed ID: 4990906
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of minocycline on meningococcal nasopharyngeal carrier state in naval personnel.
    Devine LF; Johnson DP; Hagerman CR; Pierce WE; Rhode SL; Peckinpaugh RO
    Am J Epidemiol; 1971 May; 93(5):337-45. PubMed ID: 4997355
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of trimethoprim and sulfisoxazole, alone and in combination, on growth and carriage of Neisseria meningitidis.
    Feldman HA
    J Infect Dis; 1973 Nov; 128():Suppl:723-30 p. PubMed ID: 4202210
    [No Abstract]   [Full Text] [Related]  

  • 6. Meningococcal meningitis following rifampin prophylaxis.
    Khuri-Bulos N
    Am J Dis Child; 1973 Nov; 126(5):689-91. PubMed ID: 4200808
    [No Abstract]   [Full Text] [Related]  

  • 7. Neisseria meningitidis nasopharynx colonization of diseased patients on presentation and on discharge.
    Barroso D
    Trop Doct; 1999 Apr; 29(2):108-9. PubMed ID: 10418306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Azithromycin compared with rifampin for eradication of nasopharyngeal colonization by Neisseria meningitidis.
    Girgis N; Sultan Y; Frenck RW; El-Gendy A; Farid Z; Mateczun A
    Pediatr Infect Dis J; 1998 Sep; 17(9):816-9. PubMed ID: 9779768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the effect of Rifampin on the nasopharyngeal carriage of Neisseria meningitidis. A preliminary report.
    Beam WE; Newberg NR; Devine LF
    Int Z Klin Pharmakol Ther Toxikol; 1971 Apr; 4(3):316-20. PubMed ID: 4996195
    [No Abstract]   [Full Text] [Related]  

  • 10. Seroepidemiology and chemoprophylaxis disease due to sulfonamide-resistant Neisseria meningitidis in a civillian population.
    Kaiser AB; Hennekens CH; Saslaw MS; Hayes PS; Bennett JV
    J Infect Dis; 1974 Sep; 130(3):217-24. PubMed ID: 4213375
    [No Abstract]   [Full Text] [Related]  

  • 11. Spectra of susceptibility of Neisseria meningitidis to antimicrobial agents in vitro.
    Devine LF; Hagerman CR
    Appl Microbiol; 1970 Feb; 19(2):329-34. PubMed ID: 4985432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of rifampin on the nasopharyngeal carriage of Neisseria meningitidis in a military population.
    Beam WE; Newberg NR; Devine LF; Pierce WE; Davies JA
    J Infect Dis; 1971 Jul; 124(1):39-46. PubMed ID: 5004115
    [No Abstract]   [Full Text] [Related]  

  • 13. [Meningococcus carriers among University Hospital personnel].
    de Vasconcelos RF; Melles CE; Ulson CM; Hutzler RU; Kirchner E; Stape DD; Rodrigues E
    Rev Hosp Clin Fac Med Sao Paulo; 1977 Dec; 32(6):228-34. PubMed ID: 99793
    [No Abstract]   [Full Text] [Related]  

  • 14. Prophylaxis for meningococcal disease.
    Artenstein MS
    JAMA; 1975 Mar; 231(10):1035-7. PubMed ID: 803581
    [No Abstract]   [Full Text] [Related]  

  • 15. Efficacy of rifampin in treatment of meningococcal carriers.
    Deal WB; Sanders E
    N Engl J Med; 1969 Sep; 281(12):641-5. PubMed ID: 4980025
    [No Abstract]   [Full Text] [Related]  

  • 16. Proposed model for screening antimicrobial agents for potential use in eliminating meningococci from the nasopharynx of healthy carriers.
    Devine LF; Knowles RC; Pierce WE; Peckinpaugh RO; Hagerman CR; Lytle RI
    Antimicrob Agents Chemother (Bethesda); 1968; 8():307-14. PubMed ID: 4980835
    [No Abstract]   [Full Text] [Related]  

  • 17. The meningococcal carrier-rate.
    Fraser PK; Bailey GK; Abbott JD; Gill JB; Walker DJ
    Lancet; 1973 Jun; 1(7814):1235-7. PubMed ID: 4122576
    [No Abstract]   [Full Text] [Related]  

  • 18. Eradication of carriage of Neisseria meningitidis in families: a study in Brazil.
    Munford RS; Sussuarana de Vasconcelos ZJ; Phillips CJ; Gelli DS; Gorman GW; Risi JB; Feldman RA
    J Infect Dis; 1974 Jun; 129(6):644-9. PubMed ID: 4209720
    [No Abstract]   [Full Text] [Related]  

  • 19. Field trial of the efficacy of a previously proposed regimen using minocycline and rifampin sequentially for the elimination of meningococci from healthy carriers.
    Devine LF; Pollard RB; Krumpe PE; Hoy ES; Mammen RE; Miller CH; Peckinpaugh RO
    Am J Epidemiol; 1973 Jun; 97(6):394-401. PubMed ID: 4197420
    [No Abstract]   [Full Text] [Related]  

  • 20. Does eradication of meningococcal carriage in household contacts prevent secondary cases of meningococcal disease?
    Stuart JM; Cartwright KA; Robinson PM; Noah ND
    BMJ; 1989 Mar; 298(6673):569-70. PubMed ID: 2495116
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.